# Silo Pharma, Inc. (SILO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/SILO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 18.0K | $ -1.65M | $ -822.6K | $ 0 | $ 5.68M |
| 2025 | $ 73.8K | $ -4.33M | $ -4.77M | $ 0 | $ 6.31M |
| 2024 | $ 75.8K | $ -4.62M | $ -4.03M | $ 0 | $ 5.03M |
| 2023 | $ 78.0K | $ -4.00M | $ -3.49M | $ 0 | $ 6.18M |
| 2022 | $ 80.5K | $ -4.37M | $ -3.91M | $ 0 | $ 10.34M |
| 2021 | $ 84.7K | $ 4.64M | $ -2.71M | $ 0 | $ 9.06M |
| 2020 | $ 52.1K | $ -3.87M | $ -1.47M | $ 18.9K | $ 1.28M |
| 2019 | $ 52.4K | $ -1.31M | $ -1.03M | $ 61.9K | $ -22.9K |
| 2018 | $ -115.5K | $ -1.28M | $ 360.1K | $ 22.3K | $ 407.4K |
| 2017 | $ 1.14M | $ 480.3K | $ -383.4K | $ 0 | $ 1.20M |
| 2016 | $ -921.1K | $ -1.53M | $ -197.5K | $ 0 | $ 846.5K |
| 2015 | $ -203.8K | $ -575.0K | $ -1.43M | $ 0 | $ 1.96M |
| 2014 | $ -151.4K | $ -531.6K | $ -1.50M | $ 0 | $ 2.37M |
| 2013 | $ 150.1K | $ 46.8K | $ -258.3K | $ 15.0K | $ 1.79M |
| 2012 | $ 0 | $ -57.0K | $ -31.0K | $ 20.0K | $ -41.2K |
| 2011 | $ 0 | $ -73.2K | $ -68.0K | $ 0 | $ -1.7K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.24 |
| Current Ratio | 9.65 |

## Other views

- [Metrics](https://sponda.capital/en/SILO.md)
- [Charts](https://sponda.capital/en/SILO/charts.md)
- [Compare](https://sponda.capital/en/SILO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.